Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Analysis of MMP2-1306C/T and TIMP2G-418C polymorphisms with relapsing remitting multiple sclerosis.
MS Research Roundup: August 18, 2014
Persistence with Fingolimod Versus Dimethyl Fumarate in Patients with Multiple Sclerosis: Retrospective Analysis of us Open-Source Pharmacy Data.
Integrating genome-wide association studies and gene expression data highlights dysregulated multiple sclerosis risk pathways.
Regression-Based Norms for the Brief Visuospatial Memory Test-Revised in Italian population and application in MS patients.
Evaluation of chronic inflammatory demyelinating polyneuropathy: 3D nerve-sheath signal increased with inked rest-tissue rapid acquisition of relaxation enhancement imaging (3D SHINKEI).
MS Research Roundup: December 21, 2014
Characteristics of Patients with Relapsing Remitting Multiple Sclerosis Taking Injectable and Oral Disease Modifying Treatments in the United States.
Perspectives and experiences of Dutch multiple sclerosis patients and multiple sclerosis-specialized neurologists on injectable disease-modifying treatment.
ANNALS EXPRESS: Multiple Sclerosis: Assay of Free Immunoglobulin Light Chains.
Partnership and consent in MS treatment choice.
Anti-JC virus seroprevalence in a Spanish multiple sclerosis cohort: JC virus seroprevalence in Spain.
High-throughput platforms for the screening of new therapeutic targets for neurodegenerative diseases.
Comparing Characteristics of Hungarian "Real Life" Patients With Participants of RCTS: First-Line Disease Modifying Therapies in Multiple Sclerosis.
American Society for Neurochemistry 2014
European Charcot Foundation Symposium 2012
Unilateral Optic Neuritis: A Rare Complication after Measles-Mumps-Rubella Vaccination in a 30-Year-Old Woman.
Incidence and course of depression in multiple sclerosis in the multinational BEYOND trial.
Case Report of Lewis and Sumner Syndrome with Bilateral Vagus Nerves Paralysis for 16 Years.
Persistence in Open and Closed Data Sources: A Study of Fingolimod Verse Interferons/Glatiramer Acetate in Patients with Multiple Sclerosis.
Multimodal evoked potentials follow up in multiple sclerosis patients under fingolimod therapy.
Biogen Idec Becomes Biogen
Tissue damage within normal appearing white matter in early multiple sclerosis: assessment by the ratio of T1- and T2-weighted MR image intensity.
Long-term disability and prognostic factors in polyneuropathy associated with anti-myelin- associated glycoprotein (MAG) antibodies.
CNS Remyelination and the Innate Immune System.
Pages
« first
‹ previous
…
34
35
36
37
38
39
40
41
42
…
next ›
last »